Atticus Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-143	Closed	-$63.7K	–	634
2025 Q2	$63.7K	Buy	143 +3	+2%	+$1.38K	0.02%	290
2025 Q1	$67.9K	Hold	140	–	–	0.02%	200
2024 Q4	$56.4K	Buy	140 +125	+833%	+$57.9K	0.02%	234
2024 Q3	$6.98K	Sell	15 -4	-21%	-$1.92K	﹤0.01%	414
2024 Q2	$8.91K	Hold	19	–	–	﹤0.01%	395
2024 Q1	$7.94K	Hold	19	–	–	﹤0.01%	420
2023 Q4	$7.73K	Hold	19	–	–	﹤0.01%	425
2023 Q3	$6.61K	Hold	19	–	–	﹤0.01%	440
2023 Q2	$6.69K	Hold	19	–	–	﹤0.01%	427
2023 Q1	$5.99K	Buy	19 +15	+375%	+$4.5K	﹤0.01%	424
2022 Q4	$1.16K	Sell	4 -20	-83%	-$6.09K	﹤0.01%	484
2022 Q3	$7K	Hold	24	–	–	﹤0.01%	409
2022 Q2	$7K	Buy	24 +7	+41%	+$1.87K	﹤0.01%	440
2022 Q1	$4K	Buy	+17	New	+$4.04K	﹤0.01%	484
2021 Q3	–	Sell	-347	Closed	-$70K	–	458
2021 Q2	$70K	Sell	347 -1,380	-80%	-$289K	0.03%	199
2021 Q1	$371K	Buy	1,727 +897	+108%	+$197K	0.18%	76
2020 Q4	$196K	Buy	830 +415	+100%	+$95.2K	0.1%	98
2020 Q3	$113K	Buy	415 +410	+8,200%	+$113K	0.07%	128
2020 Q2	$1K	Hold	5	–	–	﹤0.01%	291
2020 Q1	$1K	Hold	5	–	–	﹤0.01%	296
2019 Q4	$1K	Buy	+5	New	+$1.01K	﹤0.01%	370